Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Ophthalmology · Eye (Lond) · 2026-09-24
Meta-analysisn = 2,000,000
Alamoudi et al. Potential protective associations of antidiabetic and lipid-lowering therapies with retinal vein occlusion risk: a systematic review and meta-analysisCardiology · J Am Heart Assoc · 2026-08-20
Meta-analysis
Watanabe et al. Residual Atherosclerotic Cardiovascular Disease Risk in Statin Users: A Systematic Review and Meta-AnalysisGeriatrics · Lancet Healthy Longev · 2026-08-11
RCTn = 1,180
Bonnet et al. Discontinuation of statins for primary prevention of atherosclerotic cardiovascular disease in adults aged 75 years or older (SAGA/SITE): a multicentre, open-label, pragmatic, non-inferiority randomised trialGeriatrics · Age Ageing · 2026-08-03
Meta-analysisn = 288,482
Ilomäki et al. Secondary prevention of myocardial infarction in people with dementia: a multi-jurisdictional retrospective cohort study in Asia, Europe and the USAOphthalmology · Am J Ophthalmol · 2026-06-22
Meta-analysisn = 560,821
Gou et al. Association Between Statin Use and Dry Eye Disease: A Systematic Review and Meta-AnalysisCardiology · Lancet · 2026-02-05
Meta-analysisn = 123,940
Cholesterol Treatment Trialists' (CTT) Collaboration. Electronic address: [email protected] et al. Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trialsGastroenterology · Aliment Pharmacol Ther · 2026-01-10
Meta-analysisn = 81,992
Moraes et al. Statin Therapy Independently Reduces Mortality and Liver Complications in Patients With Cirrhosis: An Updated Systematic Review and Meta-Analysis